Skip to main content
XLO logo

XLO · Xilio Therapeutics, Inc.

$9.13 -0.02 (-0.22%)
Market Cap
$52.91M
Shares
5.78M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 21
Total Value: $20,748,671
Total Shares: 2,467,136

Institutional Ownership Trend

19 quarters

Holder Concentration

Across 21 13F filers
Top Holder
26.9%
Jun 2023 → Mar 2026 · range 17.1% – 41.3%
of institutional value
Top 5
81.1%
Jun 2023 → Mar 2026 · range 65.3% – 81.1%
of institutional value
Top 10
94.3%
Jun 2023 → Mar 2026 · range 89.6% – 95.8%
of institutional value
HHI
1,816
Jun 2023 → Mar 2026 · range 1,108 – 2,298
Moderately concentrated
Showing 21 of 21
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1840233 CUSIP 98422T209 13F (30d) 1 filings 1 filers Visit website Investor relations